Abstract
Purpose: There are limited data on the relationship between neighborhood level factors and their association with lung health independent of individual socioeconomic status. We sought to determine whether baseline neighborhood level socioeconomic deprivation in young adults is associated with greater 20-year decline in lung function and higher risk of future lung disease, independent of baseline individual income, education, and smoking status. Methods: This multicenter population-based cohort study included 2689 participants in Coronary Artery Risk Development in Young Adults (CARDIA) for whom neighborhood deprivation was determined at year 10 (baseline for study) and who had complete lung function measurements at years 10 and 30. Baseline neighborhood deprivation was defined using 1990 Census blocks as a combination of 4 factors involving median household income, poverty level, and educational achievement. The outcomes were decline in lung function over 20 years (year 10 to 30) and odds of emphysema (year 25). Results: In multivariable regression models, greater baseline neighborhood deprivation was associated with greater decline in lung function (−2.34 mL/year excess annual decline in forced expiratory volume in 1 second (FEV1) in the highest versus lowest deprivation quartile (P =.014)). Furthermore, baseline neighborhood deprivation was independently associated with greater odds of emphysema (odds ratio [OR] 2.99, 95% confidence interval [CI] 1.42-6.30). Conclusions: Residence in neighborhoods with greater socioeconomic deprivation in young adulthood, independent of individual income and smoking, is associated with greater 20-year decline in forced expiratory volume in 1 second and higher risk of future emphysema.
Original language | English (US) |
---|---|
Pages (from-to) | 211-218.e1 |
Journal | American journal of medicine |
Volume | 135 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2022 |
Funding
Funding: The CARDIA Lung study is funded by NHLBI (R01 HL122477). The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201800005I and HHSN268201800007I), Northwestern University (HHSN268201800003I), University of Minnesota (HHSN268201800006I), and Kaiser Foundation Research Institute (HHSN268201800004I). This manuscript has been reviewed by CARDIA for scientific content. Conflicts of Interest: ST, KNK, LAC, PG-L, DRJ, DM, TMP, MRC report none. MTD reports grants from the American Lung Association, National Institutes of Health (NIH), and Department of Defense and personal fees from AstraZeneca, GlaxoSmithKline, PulmonX, and Teva. SRR reports grants from the National Institutes of Health (NIH), American Lung Association, and AstraZeneca; personal fees from GlaxoSmithKline; and being a GSK Nucala speaker; AZ biologics in COPD study investigator, NICH PRECisE investigator, and an ACRC investigator. GRW reports grants from National Institutes of Health (NIH), Boehringer Ingelheim, BTG Interventional Medicine, and Janssen Pharmaceuticals; personal fees from Boehringer Ingelheim, Janssen Pharmaceuticals, PulmonX, Novartis, Philips, Vertex, and is a cofounder and equity share holder of Quantitative Imaging Solutions; his spouse is an employee of Biogen. RK reports grants from the National Institutes of Health (NIH) and American Lung association, and personal fees from AstraZeneca, GlaxoSmithKline, and CVS Caremark. Funding: The CARDIA Lung study is funded by NHLBI (R01 HL122477). The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201800005I and HHSN268201800007I), Northwestern University (HHSN268201800003I), University of Minnesota (HHSN268201800006I), and Kaiser Foundation Research Institute (HHSN268201800004I). This manuscript has been reviewed by CARDIA for scientific content.
Keywords
- Lung disease
- Population characteristics
- Population health
- Public health
ASJC Scopus subject areas
- General Medicine